Pangenomic Health Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was CAD 0.961441 million compared to CAD 0.80779 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago.
For the six months, net loss was CAD 2.02 million compared to CAD 1.63 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.04 a year ago.